Medtech Market Intelligence
To succeed in medtech, you need to have your finger on the pulse – but accurate, reliable information is not always easy to find. We can help you get what you need.
Fast growth in the medical technology market is driven by innovation, demographic shifts, cost-efficient development and increased M&A activity. Success in this arena depends on your ability to bring cutting-edge solutions to the fore quickly, and having accurate intelligence is crucial for a sound development strategy.
How we help
Our medtech market intelligence will keep you up-to-date with important events and help you anticipate future technology needs – so you can evaluate new market opportunities and make confident business decisions.
You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.
Key benefits:
In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.
Key benefits:
In Vivo offers comprehensive coverage of the global medical industry’s competitive landscape.
Key benefits:
In Vivo
Power your strongest strategy for the year ahead with insights from the Outlook 2021 report. A combination of Scrip’s Scrip 100, Medtech Insight’s Medtech 100, and In Vivo’s Outlook reports, Outlook 2021 is a comprehensive window into the key trends, challenges and opportunities impacting the biopharma, medtech, and generics sectors for the year to come.
Topic Outlook
Medtech Insight
The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented.
Topic Medtech
Medtech Insight
The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented.
Topic Medtech
Medtech Insight
The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented.
Topic Medtech
Medtech Insight, Meddevicetracker
Discover what’s on the horizon for spinal devices and technology with news, analysis, and data from Medtech Insight and Meddevicetracker. Keep up with the latest developments from the annual NASS meeting and explore extracts from two data-packed recent reports: Spinal Fusion Implanted Instrumentation and Spinal Motion Preservation Devices Market.
Medtech Insight
Health policy changes that President-elect Joe Biden will likely make during his four-year term include Medicaid expansion and a greater reliance on medical science, among others, experts say.
In Vivo
The COVID-19 pandemic is disrupting global supply chains and companies need effective tools to manage the related contract disputes. Sidley Austin partner Dorothee Schramm and senior associate Katie von der Weid, both specialized in international commercial disputes, provide tips to help companies manage the situation.
In Vivo
In today’s globalized market for medicines, national rules on pricing and access are abundantly shared and more transparent than opaque. In Vivo speaks to the UK branded industry’s negotiator for the latest five-year joint pricing pact with the government, Richard Torbett, who outlines, among other topics, five widely applicable precedents from the talks that can work in “getting to yes” – despite the fractious budgetary climate for health care evident in all major country markets.
Topic Brexit Policy & Regulation
Medtech Insight
The US agency has relaxed its enforcement policy for X-ray, ultrasound and magnetic resonance imaging systems, as well as software for analyzing images, as US health care workers fight the novel coronavirus.
Topic Coronavirus FDA
In Vivo
Europe’s patchwork of reimbursement agencies make it a daunting place for a small US biotech to do business. Traditionally large pharma partners or CMSOs have provided an experienced hand to hold, but as a new wave of gene therapies and orphan drugs get the EMA green light, smaller drug developers are applying innovation to commercialization and choosing to go solo.
Medtech Insight
The US Food and Drug Administration (FDA) stands poised to proceed with hastened approvals for 2019-coronavirus (nCoV) diagnostics, treatments and vaccines, if a public health emergency is declared, after an infected US traveler who caught the disease in Wuhan, China returned from the province to Washington State. Spread of the disease has reached a crisis level in China, and the World Health Organization met on 22 and 23 January to consider what actions to take to contain the virus, while issuing an interim laboratory test guidance for use in diagnosing the disease.
Topic Approvals Clinical Trials Coronavirus Policy & Regulation
Medtech Insight
As concerns continue to mount over a potential shortage of medical devices due to the closure of ethylene oxide (EtO) facilities, the US agency is looking for nine sterilizers in a pilot project that could allow them to get facility and process changes approved faster.
Topic Approvals Compliance Regulation
In Vivo
FDA guidance updated in mid-April offered workarounds for trial sponsors attempting to conduct clinical studies in a time of travel limitations, staffing changes and heightened patient safety issues. For trials involving complex products and administration, such as cell and gene therapies, sponsors must determine whether modified protocols can still maintain trial integrity. If not, it may be time to press pause.
Topic Coronavirus FDA
Medtech Insight
The US FDA has authorized marketing of a combination diagnostic that can detect either COVID-19 or influenza. The agency hopes to encourage development of additional similar tests before the fall flu season.
Topic Coronavirus Diagnostics In Vitro Diagnostics Regulation
Medtech Insight
A new template from the US FDA explains what information the agency wants to see in regulating COVID-19 tests to be performed outside the laboratory environment.
Topic Coronavirus FDA Diagnostics
Medtech Insight
22 Jan 2021
Medtech Insight
22 Jan 2021
Medtech Insight
22 Jan 2021
Medtech Insight
22 Jan 2021
Medtech Insight
22 Jan 2021
Medtech Insight
22 Jan 2021
Medtech Insight
22 Jan 2021
Medtech Insight
22 Jan 2021
Medtech Insight
21 Jan 2021
Medtech Insight
21 Jan 2021
Medtech Insight
21 Jan 2021
Medtech Insight
21 Jan 2021
Medtech Insight
21 Jan 2021
Medtech Insight
21 Jan 2021
In Vivo
20 Jan 2021
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: